Finance

Lists
Q1 2027 earnings • released • EPS beat +64.70% • Revenue beat +0.52%
See results
ANGO:NASDAQ
AngioDynamics, Inc.
$11.23
-20.86%
(-2.96) 1D
$11.49
+2.29% (+0.26)
After hours
Closed: Oct 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
$13.22
High
$13.80
Low
$11.06
Mkt. cap
472.27M
Avg. vol.
525.89K
Volume
0.00
52-wk high
$16.29
52-wk low
$9.39
EPS
-$0.88
Beta
0.30
Shares outstanding
42.05M
No. of employees
632
Open
$13.22
High
$13.80
Low
$11.06
Mkt. cap
472.27M
Avg. vol.
525.89K
Volume
0.00
52-wk high
$16.29
52-wk low
$9.39
EPS
-$0.88
Beta
0.30
Shares outstanding
42.05M
No. of employees
632
News stories
From web sources and news partners
About AngioDynamics, Inc.
CEOJames Clemmer
Employees632
FoundedFeb 9, 1988
Headquarters-
SectorMedical device
Websiteangiodynamics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ANGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current $11.23
$24.00 (+113.71%)
Average
$21.00 (+87.00%)
Lowest
$19.00 (+69.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Maintained
$20.00
+78.1%
08/11/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$19.00
+69.2%
07/16/2026
Frank Takkinen
Lake Street
Buy
Maintained
$24.00
+113.7%
07/14/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
$16.00
+42.5%
04/06/2026
Last report
Oct 8, 2026
Fiscal period
Q1 2027
-$0.04 / -$0.11
+64.70%beat
Revenue / Est. (USD)
80.92M / 80.50M
+0.52%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
75.71M
79.43M
78.42M
86.61M
Cost of goods sold
33.85M
34.65M
36.94M
39.83M
Cost of revenue
33.85M
34.65M
36.94M
39.83M
Research and development expenses
6.32M
7.63M
6.93M
8.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.78M
37.00M
38.31M
41.53M
Operating expense
49.76M
47.27M
47.91M
52.42M
Total operating expenses
83.61M
81.92M
84.85M
92.26M
Operating income
-7.90M
-2.49M
-6.43M
-5.65M
Other non operating income
-178.00K
-128.00K
4.97M
-735.00K
EBT including unusual items
-10.84M
-6.36M
-8.07M
-11.04M
EBT excluding unusual items
-8.08M
-2.72M
-1.55M
-6.49M
Income tax expense
65.00K
-5.00K
12.00K
370.00K
Effective tax rate
-0.60%
0.08%
-0.15%
-3.35%
Other operating expenses
-
-
-
138.00K
Net income
-10.90M
-6.35M
-8.08M
-11.40M
Net profit margin
-14.40%
-7.99%
-10.31%
-13.17%
Earnings per share
-0.10
-
0.02
-0.07
Interest and investment income
-
-
12.00K
1.00K
Interest expense
-4.00K
-102.00K
-100.00K
-106.00K
Net interest expenses
-4.00K
-102.00K
-88.00K
-105.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.88M
3.26M
-838.00K
-353.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps